185 related articles for article (PubMed ID: 11130185)
1. Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome.
Kim SH; Vlkolinsky R; Cairns N; Lubec G
Cell Mol Life Sci; 2000 Nov; 57(12):1810-6. PubMed ID: 11130185
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology.
Terni B; Boada J; Portero-Otin M; Pamplona R; Ferrer I
Brain Pathol; 2010 Jan; 20(1):222-33. PubMed ID: 19298596
[TBL] [Abstract][Full Text] [Related]
3. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains.
Kim SH; Fountoulakis M; Dierssen M; Lubec G
J Neural Transm Suppl; 2001; (61):109-16. PubMed ID: 11771736
[TBL] [Abstract][Full Text] [Related]
4. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.
Kim SH; Vlkolinsky R; Cairns N; Fountoulakis M; Lubec G
Life Sci; 2001 May; 68(24):2741-50. PubMed ID: 11400916
[TBL] [Abstract][Full Text] [Related]
5. Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart.
Zeng H; Saari JT; Johnson WT
J Nutr; 2007 Jan; 137(1):14-8. PubMed ID: 17182794
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.
Bosetti F; Brizzi F; Barogi S; Mancuso M; Siciliano G; Tendi EA; Murri L; Rapoport SI; Solaini G
Neurobiol Aging; 2002; 23(3):371-6. PubMed ID: 11959398
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.
Manczak M; Park BS; Jung Y; Reddy PH
Neuromolecular Med; 2004; 5(2):147-62. PubMed ID: 15075441
[TBL] [Abstract][Full Text] [Related]
8. ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis.
Ebanks B; Ingram TL; Chakrabarti L
Aging (Albany NY); 2020 Aug; 12(16):16647-16662. PubMed ID: 32853175
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease.
Beck SJ; Guo L; Phensy A; Tian J; Wang L; Tandon N; Gauba E; Lu L; Pascual JM; Kroener S; Du H
Nat Commun; 2016 May; 7():11483. PubMed ID: 27151236
[TBL] [Abstract][Full Text] [Related]
10. Animal plasma membrane energization by chemiosmotic H+ V-ATPases.
Harvey WR; Wieczorek H
J Exp Biol; 1997 Jan; 200(Pt 2):203-16. PubMed ID: 9050228
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
Coskun P; Helguera P; Nemati Z; Bohannan RC; Thomas J; Samuel SE; Argueta J; Doran E; Wallace DC; Lott IT; Busciglio J
J Alzheimers Dis; 2017; 55(2):737-748. PubMed ID: 27802222
[TBL] [Abstract][Full Text] [Related]
12. The assembly of yeast mitochondrial ATP synthase: subunit depletion in vivo suggests ordered assembly of the stalk subunits b, OSCP and d.
Straffon AF; Prescott M; Nagley P; Devenish RJ
Biochim Biophys Acta; 1998 May; 1371(2):157-62. PubMed ID: 9630594
[TBL] [Abstract][Full Text] [Related]
13. Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging.
Manczak M; Jung Y; Park BS; Partovi D; Reddy PH
J Neurochem; 2005 Feb; 92(3):494-504. PubMed ID: 15659220
[TBL] [Abstract][Full Text] [Related]
14. Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis.
Schägger H; Ohm TG
Eur J Biochem; 1995 Feb; 227(3):916-21. PubMed ID: 7867655
[TBL] [Abstract][Full Text] [Related]
15. Oligomycin sensitivity conferring protein of mitochondrial ATP synthase: deletions in the N-terminal end cause defects in interactions with F1, while deletions in the C-terminal end cause defects in interactions with F0.
Joshi S; Cao GJ; Nath C; Shah J
Biochemistry; 1996 Sep; 35(37):12094-103. PubMed ID: 8810915
[TBL] [Abstract][Full Text] [Related]
16. Single copies of subunits d, oligomycin-sensitivity conferring protein, and b are present in the Saccharomyces cerevisiae mitochondrial ATP synthase.
Bateson M; Devenish RJ; Nagley P; Prescott M
J Biol Chem; 1999 Mar; 274(11):7462-6. PubMed ID: 10066811
[TBL] [Abstract][Full Text] [Related]
17. Regulation of V-ATPases by reversible disassembly.
Kane PM
FEBS Lett; 2000 Mar; 469(2-3):137-41. PubMed ID: 10713258
[TBL] [Abstract][Full Text] [Related]
18. Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport.
Chen XQ; Das U; Park G; Mobley WC
Alzheimers Res Ther; 2021 Mar; 13(1):59. PubMed ID: 33691783
[TBL] [Abstract][Full Text] [Related]
19. Resolution and reconstitution of complex V of the mitochondrial oxidative phosphorylation system: properties and composition of the membrane sector.
Galante YM; Wong SY; Hatefi Y
Arch Biochem Biophys; 1981 Oct; 211(2):643-51. PubMed ID: 6458242
[No Abstract] [Full Text] [Related]
20. Oligomycin sensitivity-conferring protein (OSCP) of mitochondrial ATP synthase. The carboxyl-terminal region of OSCP is essential for the reconstitution of oligomycin-sensitive H(+)-ATPase.
Joshi S; Javed AA; Gibbs LC
J Biol Chem; 1992 Jun; 267(18):12860-7. PubMed ID: 1535627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
